Ofev 100 mg soft capsules, Ofev 150 mg soft capsules
APHP220273
Phase 2 small_molecule active
Quick answer
Ofev 100 mg soft capsules, Ofev 150 mg soft capsules for Adult patients aged 18 and over with unicentric hyalino-vascular Castleman's disease is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients aged 18 and over with unicentric hyalino-vascular Castleman's disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active